Literature DB >> 4358388

Rapid marked increase in plasma renin in rats treated with inhibitors of the renin system. Effects of 1-sar-8-ala-angiotensin II and of a synthetic converting enzyme inhibitor (nonapeptide, SQ 20.881) on normal and adrenalectomized rats.

J Bing.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4358388

Source DB:  PubMed          Journal:  Acta Pathol Microbiol Scand A        ISSN: 0365-4184


× No keyword cloud information.
  6 in total

1.  Entry-into-humans study with a new direct renin inhibitor.

Authors:  Laurent B Nicolas; Marcelo M Gutierrez; Christoph Binkert; Jasper Dingemanse
Journal:  Eur J Clin Pharmacol       Date:  2012-03-15       Impact factor: 2.953

2.  Effect of angiotensin-converting enzyme inhibitor on response of plasma renin activity and aldosterone to tilting in man.

Authors:  J G Collier; J S Jenkins; J Keddie; M U Khan; B F Robinson
Journal:  Br J Clin Pharmacol       Date:  1974-08       Impact factor: 4.335

3.  Aliskiren, a novel orally effective renin inhibitor, exhibits similar pharmacokinetics and pharmacodynamics in Japanese and Caucasian subjects.

Authors:  Sujata Vaidyanathan; Joanne Jermany; Chingming Yeh; Marie-Noelle Bizot; Riccardo Camisasca
Journal:  Br J Clin Pharmacol       Date:  2006-12       Impact factor: 4.335

Review 4.  Direct renin inhibition: an analysis of possible benefits.

Authors:  Brian K Dockery; John D Bisognano
Journal:  Curr Hypertens Rep       Date:  2008-08       Impact factor: 5.369

5.  Aliskiren exhibits similar pharmacokinetics in healthy volunteers and patients with type 2 diabetes mellitus.

Authors:  Charlie Zhao; Sujata Vaidyanathan; Ching-Ming Yeh; Mojdeh Maboudian; Hans Armin Dieterich
Journal:  Clin Pharmacokinet       Date:  2006       Impact factor: 6.447

Review 6.  Angiotensin receptor blockers in diabetic nephropathy.

Authors:  D A Price; N K Hollenberg
Journal:  Curr Diab Rep       Date:  2001-12       Impact factor: 4.810

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.